Clinical trial
Transfusion of CD45RA-depleted Donor Lymphocytes to Improve Regeneration of Antimicrobial Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation
NCT02337595 is registered in ClinicalTrials.gov with Federal Research Institute of Pediatric Hematology, Oncology and Immunology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transfusion of CD45RA-depleted Donor Lymphocytes to Improve Regeneration of Antimicrobial Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation
- Lead sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- January 31, 2016
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone marrow failure syndromes, graft vs host disease, immune deficiency disease, leukemia, myeloid, acute, opportunistic infections, precursor t-cell lymphoblastic leukemia-lymphoma